Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H17N5O5S |
| Molecular Weight | 427.434 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(C)=NC(NS(=O)(=O)C2=CC=C(C=C2)\N=N\C3=CC=C(O)C(=C3)C(O)=O)=N1
InChI
InChIKey=DFPJEJKMDZFZHC-GHVJWSGMSA-N
InChI=1S/C19H17N5O5S/c1-11-9-12(2)21-19(20-11)24-30(28,29)15-6-3-13(4-7-15)22-23-14-5-8-17(25)16(10-14)18(26)27/h3-10,25H,1-2H3,(H,26,27)(H,20,21,24)/b23-22+
| Molecular Formula | C19H17N5O5S |
| Molecular Weight | 427.434 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/6127793
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6127793
Salazosulfadimidine is a sulfonamide antibiotic. This drug was studied in patients with chronic inflammatory bowel disease who had developed extraintestinal manifestations when receiving sulfasalazine. Information about the current use of this drug is not available.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:17:07 GMT 2025
by
admin
on
Mon Mar 31 18:17:07 GMT 2025
|
| Record UNII |
W33009B02O
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29739
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C72843
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
991
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
219-016-6
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
SUB10419MIG
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
W33009B02O
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
DTXSID101018136
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
CHEMBL2107040
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
3537
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
2315-08-4
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
100000080542
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | |||
|
m9727
Created by
admin on Mon Mar 31 18:17:07 GMT 2025 , Edited by admin on Mon Mar 31 18:17:07 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |